OGN
Organon·NYSE
--
--(--)
--
--(--)
OGN fundamentals
Organon (OGN) Revenue Breakdown: Q4 2025 Business & Regional Performance
Organon (OGN) reported total revenue of 1.51B USD in Q4 2025, with its core business segment Women’s Health contributing 26.41%. Regionally, Europe and Canada remained the largest market, accounting for 26.87% of total revenue. Explore Organon's revenue distribution across business segments and global markets to gain insights into its growth trends and market position.
Organon (OGN) reported total revenue of 1.51B USD in Q4 2025, with its core business segment Women’s Health contributing 26.41%. Regionally, Europe and Canada remained the largest market, accounting for 26.87% of total revenue. Explore Organon's revenue distribution across business segments and global markets to gain insights into its growth trends and market position.
By Business
No Data
By Region
No Data
You can ask Aime
What guidance did Organon's management provide for the next earnings period?What is the revenue and EPS growth rate for Organon year over year?What were the key takeaways from Organon's earnings call?What is Organon's gross profit margin?What is the market's earnings forecast for Organon next quarter?What is Organon's latest dividend and current dividend yield?What does Organon do and what are its main business segments?What were the key takeaways from Organon’s earnings call?
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
